PA2G4
Basic information
Region (hg38): 12:56104537-56113910
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PA2G4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 3 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 3 | 0 | 0 |
Variants in PA2G4
This is a list of pathogenic ClinVar variants found in the PA2G4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-56106992-A-G | not specified | Uncertain significance (Feb 12, 2025) | ||
12-56109923-C-T | not specified | Uncertain significance (Nov 03, 2022) | ||
12-56111227-A-G | not specified | Uncertain significance (May 12, 2024) | ||
12-56111262-C-T | not specified | Uncertain significance (May 21, 2024) | ||
12-56111275-A-G | not specified | Uncertain significance (Feb 20, 2025) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PA2G4 | protein_coding | protein_coding | ENST00000303305 | 13 | 9589 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.999 | 0.00124 | 125745 | 0 | 2 | 125747 | 0.00000795 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.52 | 74 | 222 | 0.334 | 0.0000113 | 2619 |
Missense in Polyphen | 6 | 53.461 | 0.11223 | 715 | ||
Synonymous | 1.33 | 65 | 80.1 | 0.811 | 0.00000427 | 715 |
Loss of Function | 4.34 | 1 | 23.9 | 0.0419 | 0.00000117 | 289 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000183 | 0.0000176 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May play a role in a ERBB3-regulated signal transduction pathway. Seems be involved in growth regulation. Acts a corepressor of the androgen receptor (AR) and is regulated by the ERBB3 ligand neuregulin-1/heregulin (HRG). Inhibits transcription of some E2F1-regulated promoters, probably by recruiting histone acetylase (HAT) activity. Binds RNA. Associates with 28S, 18S and 5.8S mature rRNAs, several rRNA precursors and probably U3 small nucleolar RNA. May be involved in regulation of intermediate and late steps of rRNA processing. May be involved in ribosome assembly. Mediates cap-independent translation of specific viral IRESs (internal ribosomal entry site) (By similarity). Regulates cell proliferation, differentiation, and survival. Isoform 1 suppresses apoptosis whereas isoform 2 promotes cell differentiation (By similarity). {ECO:0000250|UniProtKB:P50580, ECO:0000250|UniProtKB:Q6AYD3, ECO:0000269|PubMed:11268000, ECO:0000269|PubMed:12682367, ECO:0000269|PubMed:15064750, ECO:0000269|PubMed:15583694, ECO:0000269|PubMed:16832058}.;
- Pathway
- Neutrophil degranulation;Innate Immune System;Immune System;Coregulation of Androgen receptor activity
(Consensus)
Recessive Scores
- pRec
- 0.223
Intolerance Scores
- loftool
- rvis_EVS
- -0.3
- rvis_percentile_EVS
- 32.62
Haploinsufficiency Scores
- pHI
- 0.960
- hipred
- Y
- hipred_score
- 0.681
- ghis
- 0.647
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.444
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pa2g4
- Phenotype
- growth/size/body region phenotype; cellular phenotype; hematopoietic system phenotype; reproductive system phenotype; limbs/digits/tail phenotype;
Gene ontology
- Biological process
- rRNA processing;regulation of translation;cell cycle arrest;cell population proliferation;negative regulation of apoptotic process;neutrophil degranulation;positive regulation of cell differentiation;negative regulation of transcription, DNA-templated
- Cellular component
- extracellular region;nucleus;nucleolus;cytoplasm;membrane;azurophil granule lumen;extracellular exosome
- Molecular function
- nucleic acid binding;DNA binding;DNA-binding transcription factor activity;RNA binding;protein binding;ubiquitin protein ligase binding